Joe Kiani

A Story of Innovation

Under his leadership, Masimo has grown from a “garage start up” into a successful publicly traded company (NASDAQ:  MASI) employing more than 4,500 people worldwide and providing its technologies directly and through leading OEM patient monitoring manufacturers worldwide. Mr. Kiani and Masimo have helped to solve the “unsolvable” problems plaguing patient monitoring through significant inventions with more than 600 issued and pending patents worldwide.  Masimo is an innovative powerhouse delivering key noninvasive medical breakthroughs, including: rainbow SET Pulse CO-Oximetry™—the first blood constituent monitoring platform to measure multiple blood constituents noninvasively that previously could only be measured invasively and help clinicians improve patient safety and reduce cost of care.  Masimo also introduced wearable rainbow SET Radius-7 as well as the bedside rainbow SET Radical-7 and Patient SafetyNet™—the first remote monitoring and wireless clinician notification system shown to help hospitals improve patient safety and clinical outcomes by dramatically decreasing rescue events and costly ICU transfers. Patient SafetyNet is helping hospitals save lives in places like the post-surgical wards where reliable monitoring was not feasible before due to excessive false alarms. With Root’s new open architecture, cockpit and connectivity hub patient monitoring platform, clinical distraction, complexity and cost are expected to decrease and innovation in patient monitoring are expected to accelerate. New Masimo apps and products are detecting Critical Congenital Heart Disease and pneumonia in infants and preventing  deaths due to opioid overdose with remote surveillance  and clinical notification for signs of respiratory depression.


As founder, Chairman and CEO of Masimo, Joe Kiani runs one of the most admired medical technology companies in the world.  He co-invented – SET® Measure-through Motion and Low Perfusion pulse oximetry.  Studies have shown that this revolutionary technology can reduce false alarms in pulse oximetry by 95%, can help detect life threatening events, can help reduce blindness in premature babies and can help identify the existence of congenital heart conditions in newborns.  In 2012, Kiani founded the non-profit, Patient Safety Movement Foundation (PSMF) with a commitment to eliminate preventable patient deaths in US hospitals and significantly reduce medical errors worldwide by the year 2020 (#0x2020). Over 4,500 hospitals have made a formal and public commitment to zero preventable deaths and over 100 healthcare technology companies have made a public pledge to share their data so that researchers can develop predictive algorithms that notify clinicians of dangerous trends. This worldwide collaboration is hoping to foster a “patient data superhighway” that will catch errors before they cause harm. In February 2018, the hospitals that had joined Patient Safety Movement reported 81,533 lives saved annually.